[1]
|
Xu, X.F., Liu, G.X., Guo, Y.S., et al. (2021) Global, Regional, and National Incidence and Year Lived with Disability for Benign Prostatic Hyperplasia from 1990 to 2019. American Journal of Men’s Health, 15. https://doi.org/10.1177/15579883211036786
|
[2]
|
Carson, C.R. and Rittmaster, R. (2003) The Role of Dihydrotestosterone in Benign Prostatic Hyperplasia. Urology, 61, 2-7. https://doi.org/10.1016/S0090-4295(03)00045-1
|
[3]
|
Chapple, C.R. (2005) A Comparison of Varying α-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. Reviews in Urology, 7, S22-S30.
|
[4]
|
Dahm, P., Brasure, M., Macdonald, R., et al. (2017) Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. European Urology, 71, 570-581. https://doi.org/10.1016/j.eururo.2016.09.032
|
[5]
|
Malde, S., Umbach, R., Wheeler, J.R., et al. (2021) A Systematic Review of Patients’ Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms. European Urology, 79, 796-809. https://doi.org/10.1016/j.eururo.2020.12.019
|
[6]
|
Leslie, S.W., Chargui, S. and Stormont, G. (2023) Transurethral Resection of the Prostate.
|
[7]
|
Wang, B., Zhang, S., Sun, C., et al. (2020) Comparison between a Transurethral Prostate Split and Transurethral Prostate Resection for Benign Prostatic Hyperplasia Treatment in a Small Prostate Volume: A Prospective Controlled Study. Annals of Translational Medicine, 8, Article 1016. https://doi.org/10.21037/atm-20-5462
|
[8]
|
Rassweiler, J., Teber, D., Kuntz, R., et al. (2006) Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and Prevention. European Urology, 50, 969-980. https://doi.org/10.1016/j.eururo.2005.12.042
|
[9]
|
Alexander, C.E., Scullion, M., Omar, M.I., et al. (2020) Reprint—Bipolar vs. Monopolar Transurethral Resection of the Prostate for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Obstruction: A Cochrane Review. Canadian Urological Association Journal, 14, 423-430. https://doi.org/10.5489/cuaj.6464
|
[10]
|
Gupta, A., Priyadarshi, S., Vyas, N. and Sharma, G. (2021) Efficacy of Tranexamic Acid in Decreasing Primary Hemorrhage in Transurethral Resection of the Prostate: A Novel Combination of Intravenous and Topical Approach. Urology Annals, 13, 238-242. https://doi.org/10.5489/cuaj.6464
|
[11]
|
Tsai, M.Y., Chen, C.H., Chiang, P.H. and Chiang, P.C. (2023) Combination of 180-W GreenLight XPS Laser and Bipolar Transurethral Resection of Prostate for the Treatment of Large Prostates beyond 100 Ml: A Novel Hybrid Technique. International Urology and Nephrology, 55, 2741-2746. https://doi.org/10.1007/s11255-023-03723-w
|
[12]
|
Yang, C.Y., Chen, G.M., Wu, Y.X., et al. (2023) Clinical Efficacy and Complications of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate. European Journal of Medical Research, 28, Article No. 83. https://doi.org/10.1186/s40001-023-00989-9
|
[13]
|
Bolliger, M., Kroehnert, J.A., Molineus, F., et al. (2018) Experiences with the Standardized Classification of Surgical Complications (Clavien-Dindo) in General Surgery Patients. European Surgery, 50, 256-261. https://doi.org/10.1007/s10353-018-0551-z
|
[14]
|
Zou, Z., Zhang, L., Cai, K., et al. (2023) Feasibility and Safety of Bipolar-Plasmakinetic Transurethral Enucleation and Resection of the Prostate in Day Surgery Mode. Journal of Zhejiang University, 52, 148-155. https://doi.org/10.3724/zdxbyxb-2022-0643
|
[15]
|
Kuntz, R.M., Ahyai, S., Lehrich, K., et al. (2004) Transurethral Holmium Laser Enucleation of the Prostate versus Transurethral Electrocautery Resection of the Prostate: A Randomized Prospective Trial in 200 Patients. Journal of Urology, 172, 1012-1016. https://doi.org/10.1097/01.ju.0000136218.11998.9e
|
[16]
|
He, W., Ding, T., Niu, Z., et al. (2023) Reoperation after Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review. Frontiers in Endocrinology, 14, Article 1287212. https://doi.org/10.3389/fendo.2023.1287212
|
[17]
|
Tamalunas, A., Westhofen, T., Schott, M., et al. (2022) Holmium Laser Enucleation of the Prostate: A Truly Size-Independent Method? LUTS: Lower Urinary Tract Symptoms, 14, 17-26. https://doi.org/10.1111/luts.12404
|
[18]
|
Porto, J.G., Blachman-Braun, R., Delgado, C., et al. (2023) Is Holmium Laser Enucleation of the Prostate Truly Size-Independent? A Critical Evaluation at the Extreme Ends of the Spectrum. Urology, 182, 204-210. https://doi.org/10.1016/j.urology.2023.09.002
|
[19]
|
Nishino, T., Endo, F., Nakama, D., et al. (2024) Holmium Laser Enucleation of the Prostate as a Secondary Surgery Following Prostatic Urethral Lift. IJU Case Reports, 7, 34-37. https://doi.org/10.1002/iju5.12661
|
[20]
|
Shoma, A.M., Ghobrial, F.K., El-Tabey, N., et al. (2023) A Randomized Trial of Holmium Laser vs Thulium Laser vs Bipolar Enucleation of Large Prostate Glands. BJU International, 132, 686-695. https://doi.org/10.1111/bju.16174
|
[21]
|
Wen, Z., Deng, X.Z., Wang, L., et al. (2023) Efficacy and Safety of Transurethral Thulium Laser Enucleation versus Robot-Assisted Prostatectomy for Large-Volume Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. Journal of Robotic Surgery, 17, 2633-2646. https://doi.org/10.1007/s11701-023-01715-7
|
[22]
|
Gao, Y.A., Huang, Y., Zhang, R., et al. (2014) Benign Prostatic Hyperplasia: Prostatic Arterial Embolization versus Transurethral Resection of the Prostate—A Prospective, Randomized, and Controlled Clinical Trial. Radiology, 270, 920-928. https://doi.org/10.1148/radiol.13122803
|
[23]
|
De Assis, A.M., Moreira, A.M., Carnevale, F.C., et al. (2021) Role of Ultrasound Elastography in Patient Selection for Prostatic Artery Embolization. Journal of Vascular and Interventional Radiology, 32, 1410-1416. https://doi.org/10.1016/j.jvir.2021.07.018
|
[24]
|
Radwan, A., Farouk, A., Higazy, A., et al. (2020) Prostatic Artery Embolization versus Transurethral Resection of the Prostate in Management of Benign Prostatic Hyperplasia. Prostate International, 8, 130-133. https://doi.org/10.1016/j.prnil.2020.04.001
|
[25]
|
Bilhim, T., Costa, N.V., Torres, D., et al. (2022) Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients over a 10-Year Period. CardioVascular and Interventional Radiology, 45, 1324-1336. https://doi.org/10.1007/s00270-022-03199-8
|
[26]
|
Guerra, X., Sapoval, M., Querub, C., et al. (2023) Repeat Prostatic Artery Embolization with the Addition of a Liquid Embolic Agent: Short-Term Results. Academic Radiology. https://doi.org/10.1016/j.acra.2023.10.005
|
[27]
|
Ayyagari, R., Powell, T., Staib, L., et al. (2020) Prostatic Artery Embolization Using 100-300-Mum Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-Up. Journal of Vascular and Interventional Radiology, 31, 99-107. https://doi.org/10.1016/j.jvir.2019.08.005
|
[28]
|
Zhiyu, Z., Zhen, S., Qi, Z., et al. (2023) Two-Year Outcomes after Transurethral Prostate Resection Post-Prostatic Artery Embolization versus Transurethral Prostate Resection Alone for Giant Benign Prostatic Hyperplasia. Urology Journal, 20, 361-368.
|
[29]
|
Wu, X., Zhou, A., Heller, M. and Kohlbrenner, R. (2022) Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis. Journal of Vascular and Interventional Radiology, 33, 1605-1615. https://doi.org/10.1016/j.jvir.2022.08.006
|
[30]
|
Xu, X.J., Li, J., Huang, X.Z. and Liu, Q. (2020) An Updated Meta-Analysis of Prostatic Arterial Embolization versus Transurethral Resection of the Prostate in the Treatment of Benign Prostatic Hyperplasia. World Journal of Urology, 38, 2455-2468. https://doi.org/10.1007/s00345-019-03044-7
|
[31]
|
Arezki, A., Sadri, I., Couture, F., et al. (2021) Reasons to Go for Rezum Steam Therapy: An Effective and Durable Outpatient Minimally Invasive Procedure. World Journal of Urology, 39, 2307-2313. https://doi.org/10.1007/s00345-020-03457-9
|
[32]
|
Alegorides, C., Fourmarier, M., Eghazarian, C., et al. (2020) Treatment of Benign Prostate Hyperplasia Using the Rezum® Water Vapor Therapy System: Results at One Year. Progrès en Urologie, 30, 624-631. https://doi.org/10.1016/j.purol.2020.05.004
|
[33]
|
Campobasso, D., Siena, G., Chiodini, P., et al. (2023) Composite Urinary and Sexual Outcomes after Rezum: An Analysis of Predictive Factors from an Italian Multi-Centric Study. Prostate Cancer and Prostatic Diseases, 26, 410-414. https://doi.org/10.1038/s41391-022-00587-6
|
[34]
|
Bausch, K., Zahiti, L., Schrutt, M., et al. (2023) Water Vapor Thermal Therapy of Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Efficacy and Safety Analysis of a Real-World Cohort of 211 Patients. World Journal of Urology, 41, 1605-1612. https://doi.org/10.1007/s00345-023-04395-y
|
[35]
|
(2022) The Global, Regional, and National Burden of Benign Prostatic Hyperplasia in 204 Countries and Territories from 2000 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Healthy Longevity, 3, E754-E776.
|
[36]
|
Balakrishnan, D., Jones, P. and Somani, B.K. (2020) ITIND: The Second-Generation Temporary Implantable Nitinol Device for Minimally Invasive Treatment of Benign Prostatic Hyperplasia. Therapeutic Advances in Urology, 12. https://doi.org/10.1177/1756287220934355
|
[37]
|
Elterman, D., Gao, B., Zorn, K.C., et al. (2021) How I Do It: Temporarily Implanted Nitinol Device (ITind). The Canadian Journal of Urology, 28, 10788-10793.
|
[38]
|
Porpiglia, F., Fiori, C., Bertolo, R., et al. (2015) Temporary Implantable Nitinol Device (TIND): A Novel, Minimally Invasive Treatment for Relief of Lower Urinary Tract Symptoms (LUTS) Related to Benign Prostatic Hyperplasia (BPH): Feasibility, Safety and Functional Results at 1 Year of Follow-Up. BJU International, 116, 278-287. https://doi.org/10.1111/bju.12982
|
[39]
|
Porpiglia, F., Fiori, C., Bertolo, R., et al. (2018) 3-Year Follow-Up of Temporary Implantable Nitinol Device Implantation for the Treatment of Benign Prostatic Obstruction. BJU International, 122, 106-112. https://doi.org/10.1111/bju.14141
|
[40]
|
Amparore, D., De Cillis, S., Schulman, C., et al. (2023) Temporary Implantable Nitinol Device for Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms: Over 48-Month Results. Minerva Urology and Nephrology, 75, 743-751. https://doi.org/10.23736/S2724-6051.23.05322-3
|
[41]
|
Chin, P.T., Bolton, D.M., Jack, G., et al. (2012) Prostatic Urethral Lift: Two-Year Results after Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urology, 79, 5-11. https://doi.org/10.1016/j.urology.2011.10.021
|
[42]
|
Magistro, G., Stief, C.G. and Gratzke, C. (2017) Prostatic Urethral Lift versus Transurethral Resection of the Prostate (TURP). Current Urology Reports, 18, Article No. 82. https://doi.org/10.1007/s11934-017-0725-4
|
[43]
|
Feiertag, J.H., Kane, J.A. and Clark, J.Y. (2024) Incidence of Surgical Reintervention for Benign Prostatic Hyperplasia Following Prostatic Urethral Lift, Transurethral Resection of the Prostate, and Photoselective Vaporization of the Prostate: A TriNetX Analysis. European Urology Open Science, 59, 63-70. https://doi.org/10.1016/j.euros.2023.11.009
|
[44]
|
Rochester, M., Doherty, R., Page, T., et al. (2024) Prostatic Urethral Lift for Subjects in Urinary Retention (PULSAR): 12-Month Results of A Prospective Controlled Trial Compared with Real-World Outcomes. BJUI Compass, 5, 60-69. https://doi.org/10.1002/bco2.280
|
[45]
|
Elterman, D., Shepherd, S., Saadat, S.H., et al. (2021) Prostatic Urethral Lift (UroLift) versus Convective Water Vapor Ablation (Rezum) for Minimally Invasive Treatment of BPH: A Comparison of Improvements and Durability in 3-Year Clinical Outcomes. The Canadian Journal of Urology, 28, 10824-10833.
|